UTMB Taps DoseMe’s Genetic Biomarker Capabilities for Precision Dosing

UTMB Taps DoseMe’s Genetic Biomarker Capabilities for Precision Dosing

Business Wire

Published

JUPITER, Fla.--(BUSINESS WIRE)--DoseMe, a leading provider of precision dosing software for therapeutic drug monitoring and creators of DoseMeRx and DoseMe Analytics, today announced University of Texas Medical Branch (UTMB) will utilize the DoseMe platform to advance its genetic biomarker‐driven precision dosing program. UTMB set out to address the fact they were not providing enough clinical services based on genomics. “It was not standard practice for the pharmacy to be involved and we knew

Full Article